Decane

Decane

SCHEMBL7127175

Br.CCCCCCCCCC

nearest known ligand 0.89

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ACHEADRA1AADRA1BADRA1DADRA2AADRA2BADRA2CADRB1ADRB2ADRB3APH1AAPH1BCHRM2CHRM3EZH2GRIN2AHTR1AHTR1BHTR1DHTR1FHTR3ANCSTNP2RY12PSEN1PSEN2PSENENSIGMAR1SLC6A2SLC6A3SLC6A4

The experimentally established mechanism targets of Decane. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 9)

geneUniProtsupporting neighboursconfidence
TSHR P16473 5/20 0.89
THRB P10828 1/20 0.89
DNM1 Q05193 7/20 0.64
LMNA P02545 3/20 0.60
ALDH1A1 P00352 3/20 0.57
MEN1 O00255 2/20 0.57
KMT2A Q03164 2/20 0.57
HSD17B10 Q99714 1/20 0.57
SLC22A1 O15245 1/20 0.57

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Decane SCHEMBL8345709 1.00 TSHR (0.89) TSHRTHRBDNM1LMNAALDH1A1
Heptane SCHEMBL2316247 1.00
Dodecane SCHEMBL3296654 1.00 TSHR (0.89) TSHRTHRBDNM1LMNAALDH1A1
Octane SCHEMBL9775420 1.00 TSHR (0.89) TSHRTHRBDNM1LMNAALDH1A1
Nonane SCHEMBL9775414 1.00 TSHR (0.89) TSHRTHRBDNM1LMNAALDH1A1
Tetradecane SCHEMBL25287499 1.00 TSHR (0.89) TSHRTHRBDNM1LMNAALDH1A1
Nonane SCHEMBL9775419 1.00 TSHR (0.89) TSHRTHRBDNM1LMNAALDH1A1
Hexadecane SCHEMBL22470776 1.00 TSHR (0.89) TSHRTHRBDNM1LMNAALDH1A1
Decane SCHEMBL22470775 1.00 TSHR (0.89) TSHRTHRBDNM1LMNAALDH1A1
Decane SCHEMBL6294371 1.00 TSHR (0.89) TSHRTHRBDNM1LMNAALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 100 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2025002452-A1 LIQUID ORGANIC COMPOSITION FOR LITHIUM EXTRACTION, AND PREPARATION METHOD THEREFOR 北京索特莱克科技发展有限公司 2025-01-02 WO claimed
CN-119101050-A Liquid crystal molecular compound and preparation method and application thereof 长江师范学院 2024-12-10 CN claimed
CN-118185608-A Janus carbon nano tube viscosity reducer particle, preparation method and thickened oil viscosity reducing method 中海石油(中国)有限公司 2024-06-14 CN claimed
CN-116693785-B Nitrogen-containing heterocyclic polymer, polymer film and application thereof 武汉立膜科技有限公司 2024-02-09 CN claimed
CN-117285819-A High-conductivity high-flexibility composite material, ion exchange membrane and application thereof 武汉立膜科技有限公司 2023-12-26 CN claimed
CN-117285701-A Nitrogen-containing heterocyclic polymer with cross-linking group at tail end, polymer film and application thereof 武汉立膜科技有限公司 2023-12-26 CN claimed
CN-116693785-A Nitrogen-containing heterocyclic polymer, polymer film and application thereof 武汉立膜科技有限公司 2023-09-05 CN claimed
CN-116023333-A Bio-based imidazole and preparation method and application thereof 贵州大学 2023-04-28 CN claimed
CN-115417850-B Application of catalyst containing spiro-cyclic compound in catalyzing reaction of epoxy compound and carbon dioxide 深圳新宙邦科技股份有限公司 2023-04-18 CN claimed
CN-115745765-A Preparation method of p-bromoalkylcyclohexanone compounds 浙大宁波理工学院 2023-03-07 CN claimed
CN-115417850-A Application of catalyst containing spiro-cyclic compound in catalyzing reaction of epoxy compound and carbon dioxide 深圳新宙邦科技股份有限公司 2022-12-02 CN claimed
CN-114736657-A Alkyl imidazole ionic liquid containing fatty acid group and preparation method and application thereof 华南理工大学 2022-07-12 CN claimed
CN-111087392-B Vinyl conjugated indolylaminothiazole compound and preparation method and application thereof 西南大学 2022-06-03 CN claimed
CN-110669165-B Cationic polyacrylate fluorine-free waterproof agent and preparation method thereof 陕西科技大学 2022-04-12 CN claimed
CN-107540599-B Aminoindane compounds and their use to treat pain 阿萨纳生物科技有限责任公司 2021-06-04 CN claimed
WO-2014028675-A1 USE OF AMINOINDANE COMPOUNDS IN TREATING OVERACTIVE BLADDER AND INTERSTITIAL CYSTITIS ENDO PHARMACEUTICALS INC. (US) 2014-02-20 WO claimed
US-12616964-B2 Spirocyclic compound containing catalyst for use in catalyzing reaction of epoxide compound and carbon dioxide SHENZHEN CAPCHEM TECHNOLOGY CO., LTD. (CN) 2026-05-05 US disclosed
CN-119684319-A A-DA' D-A type non-fullerene small molecule acceptor material based on inner linear alkyl, and preparation method and application thereof 山东大学 2025-03-25 CN disclosed
EP-0627406-A1 2-AMINO-1,3-PROPANEDIOL COMPOUND AND IMMUNOSUPPRESSANT YOSHITOMI PHARMACEUTICAL INDUSTRIES, LTD. (JP) 1994-12-07 EP disclosed
CN-87103235-A The photosensitive azole pesticides 1988-06-08 CN disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12616964-B2 Spirocyclic compound containing catalyst for use in catalyzing reaction of epoxide compound and carbon dioxide RCC2, NR3C2, CA2 TSHR 593/4885THRB 1644/4885DNM1 4284/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.